KeyBanc reiterates overweight rating on CareTrust REIT stock

Published 18/06/2025, 15:32
KeyBanc reiterates overweight rating on CareTrust REIT stock

KeyBanc Capital Markets maintained its overweight rating and $33.00 price target on CareTrust REIT (NYSE:CTRE) stock on Wednesday. The healthcare REIT, currently valued at $5.6 billion, boasts a "GREAT" financial health score according to InvestingPro analysis. The firm’s decision follows an update from PACS Group, CareTrust’s second-largest tenant representing approximately 12% of rent.

PACS Group disclosed on Monday that it plans to restate its first and second quarter 2024 financial statements due to issues related to Medicare Part B billing. The restatement stems from an ongoing independent investigation following a Hindenburg Research report published in November 2024, which led to delays in PACS filing its third quarter 2024 financials. Despite these tenant concerns, CareTrust maintains impressive gross profit margins of 94.5% and operates with a conservative debt profile.

The estimated revenue restatement amounts to approximately 2% of PACS’s first quarter 2024 revenue and 5% of its second quarter 2024 revenue. KeyBanc characterized these adjustments as "benign" and noted they should have limited impact on CareTrust’s rent coverage, potentially affecting it by up to 0.3x.

PACS indicated the independent investigation is substantially complete, though the operator expects to report one or more material weaknesses. The financial impact from the investigation and potential fines remain unknown, and PACS has not filed quarterly or annual financial statements through the first quarter of 2025.

KeyBanc continues to view CareTrust REIT as an attractive investment opportunity to gain exposure to favorable long-term care fundamentals, citing the company’s attractive cost of capital, strong balance sheet, and above-average earnings growth profile. The company offers a compelling 4.6% dividend yield and has raised its dividend for nine consecutive years. For deeper insights into CareTrust’s investment potential, including 12 additional ProTips and comprehensive valuation analysis, visit InvestingPro.

In other recent news, CareTrust REIT, Inc. has secured a $500 million unsecured term loan facility, enhancing its financial flexibility and capital foundation. The company plans to use the proceeds to pay off an existing revolver balance of approximately $475 million, finance acquisitions, and for general corporate purposes. Additionally, CareTrust has expanded its leadership team by appointing Roger Laty as Senior Vice President of Tax and Derek Bunker as Senior Vice President of Strategy and Investor Relations. The company has also completed a significant acquisition, purchasing 10 skilled nursing facilities for approximately $146 million in a joint venture, further expanding its portfolio. In terms of credit ratings, Moody’s has affirmed CareTrust’s Ba1 rating while revising its outlook to positive, citing consistent operational performance and strong liquidity. Fitch Ratings has upgraded CareTrust’s ratings to ’BBB-’ following the acquisition of UK-based Care REIT, highlighting improved diversification and low leverage. These developments reflect CareTrust’s strategic efforts to grow and diversify its healthcare real estate portfolio while maintaining financial stability.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.